PRIA Logo™
119-hr-4605119th CongressWALLET

End Prescription Drug Ads Now Act

Sponsored By: Representative Nadler, Jerrold [D-NY-12]

Introduced

Summary

Would restrict direct-to-consumer prescription drug advertising by creating a new rule in the Federal Food, Drug, and Cosmetic Act that triggers limits when a drug maker ran consumer-targeted ads in the prior 30 days. It defines "direct-to-consumer advertising" to include television, radio, print, digital platforms, and social media and ties coverage to drugs approved under section 505 or licensed under section 351 that are subject to section 503(b)(1).

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 0 benefits, 0 costs, 1 mixed.

Ban on prescription drug ads

This bill would ban drug makers from running ads aimed at consumers for certain prescription drugs. TV, radio, print, websites, and social media would all count as ads. It would apply to FDA-approved or licensed prescription drugs if the maker advertised that drug in the prior 30 days. The rule would take effect 30 days after enactment and would apply no matter when the drug was approved. Households could see fewer drug ads, and some people might get less information from ads.

Sponsors & CoSponsors

Sponsor

Nadler, Jerrold [D-NY-12]

NY • D

Cosponsors

  • Rep. Dexter, Maxine [D-OR-3]

    OR • D

    Sponsored 7/22/2025

  • Rep. Omar, Ilhan [D-MN-5]

    MN • D

    Sponsored 7/23/2025

  • Rep. Tlaib, Rashida [D-MI-12]

    MI • D

    Sponsored 9/2/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation